Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 76 AL 90

Screening strategies to identify HSP70 modulators to treat Alzheimer's disease

Repalli J, Meruelo D.

Drug Des Devel Ther. 2015 Jan 7;9:321-31. doi: 10.2147/DDDT.S72165. eCollection 2015.

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy

Campbell NL, Skaar TC, Perkins AJ, Gao S, Li L, Khan BA, Boustani MA.

Clin Interv Aging. 2015 Jan 14;10:269-75. doi: 10.2147/CIA.S65980. eCollection 2015.

Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease

Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J.

J Alzheimers Dis. 2015;45(3):709-19. doi: 10.3233/JAD-143099.

MicroRNA landscape in Alzheimer's disease

Cogoni C, Ruberti F, Barbato C.

CNS Neurol Disord Drug Targets. 2015;14(2):168-75. doi: 10.2174/1871527314666150116123305.

Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study

Wang X, Hjorth E, Vedin I, Eriksdotter M, Freund-Levi Y, Wahlund LO, Cederholm T, Palmblad J, Schultzberg M.

J Lipid Res. 2015 Mar;56(3):674-681. doi: 10.1194/jlr.P055418. Epub 2015 Jan 23.

Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies?

Ferreira ME, de Vasconcelos AS, da Costa Vilhena T, da Silva TL, da Silva Barbosa A, Gomes AR, Dolabela MF, Percário S.

Cell Mol Neurobiol. 2015 Jul;35(5):595-614. doi: 10.1007/s10571-015-0157-y. Epub 2015 Jan 24.

Statins and cognitive function: an updated review

Chatterjee S, Krishnamoorthy P, Ranjan P, Roy A, Chakraborty A, Sabharwal MS, Ro R, Agarwal V, Sardar P, Danik J, Giri JS, DeGoma EM, Kumbhani DJ.

Curr Cardiol Rep. 2015 Feb;17(2):4. doi: 10.1007/s11886-014-0559-3.

Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer's disease

van Leeuwen LA, Hoozemans JJ.

Acta Neuropathol. 2015 Apr;129(4):511-25. doi: 10.1007/s00401-015-1382-7. Epub 2015 Jan 25.

Apolipoprotein E ε4 modulates functional brain connectome in Alzheimer's disease

Wang J, Wang X, He Y, Yu X, Wang H, He Y.

Hum Brain Mapp. 2015 May;36(5):1828-46. doi: 10.1002/hbm.22740. Epub 2015 Jan 24.

Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection

Kaur U, Banerjee P, Bir A, Sinha M, Biswas A, Chakrabarti S.

Curr Top Med Chem. 2015;15(5):446-57. doi: 10.2174/1568026615666150114160543.

Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol

Apostolova LG, Zarow C, Biado K, Hurtz S, Boccardi M, Somme J, Honarpisheh H, Blanken AE, Brook J, Tung S, Lo D, Ng D, Alger JR, Vinters HV, Bocchetta M, Duvernoy H, Jack CR Jr, Frisoni GB; EADC-ADNI Working Group on the Harmonized Protocol for Manual Hippocampal Segmentation.

Alzheimers Dement. 2015 Feb;11(2):139-50. doi: 10.1016/j.jalz.2015.01.001. Epub 2015 Jan 22.

The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease

Blair LJ, Baker JD, Sabbagh JJ, Dickey CA.

J Neurochem. 2015 Apr;133(1):1-13. doi: 10.1111/jnc.13033. Epub 2015 Feb 24.

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study

Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P; Australian Imaging, Biomarkers, and Lifestyle Research Group.

JAMA Psychiatry. 2015 Mar;72(3):284-91. doi: 10.1001/jamapsychiatry.2014.2476.

The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer's Disease

Gomes B, Loureiro JA, Coelho MA, Pereira Mdo C.

Curr Pharm Des. 2015;21(39):5725-35. doi: 10.2174/1381612821666150130120358.

BRCA1 and p53 tumor suppressor molecules in Alzheimer's disease

Nakanishi A, Minami A, Kitagishi Y, Ogura Y, Matsuda S.

Int J Mol Sci. 2015 Jan 28;16(2):2879-92. doi: 10.3390/ijms16022879.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias